Moderna
MRNA
MRNA
1,064 hedge funds and large institutions have $44.5B invested in Moderna in 2022 Q4 according to their latest regulatory filings, with 244 funds opening new positions, 299 increasing their positions, 363 reducing their positions, and 72 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.54% more ownership
Funds ownership: 63.06% → 64.6% (+1.5%)
10% more call options, than puts
Call options by funds: $3.69B | Put options by funds: $3.37B
18% less repeat investments, than reductions
Existing positions increased: 299 | Existing positions reduced: 363
Holders
1,064
Holding in Top 10
33
Calls
$3.69B
Puts
$3.37B
Top Buyers
| 1 | +$360M | |
| 2 | +$278M | |
| 3 | +$268M | |
| 4 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
+$243M |
| 5 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$162M |
Top Sellers
| 1 | -$667M | |
| 2 | -$164M | |
| 3 | -$122M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$88.6M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$84.8M |